APO Research
Talk to an analyst

APO RESEARCH · REPORT

Preventive Asthma Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Preventive Asthma Drug Market Analysis and Forecast 2026-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchPreventive Asthma Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Preventive Asthma Drug Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Preventive Asthma Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preventive Asthma Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Preventive Asthma Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Preventive Asthma Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Preventive Asthma Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Preventive Asthma Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Preventive Asthma Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Preventive Asthma Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Preventive Asthma Drug include Callisto Pharmaceuticals, Molecular Insight Pharmaceuticals, Xiaflex, Roche and Novartis AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Preventive Asthma Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Preventive Asthma Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Preventive Asthma Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Preventive Asthma Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Preventive Asthma Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Preventive Asthma Drug sales, projected growth trends, production technology, application and end-user industry.

Preventive Asthma Drug Segment by Company

Callisto Pharmaceuticals

Molecular Insight Pharmaceuticals

Xiaflex

Roche

Novartis AG

Preventive Asthma Drug Segment by Type

Somatostatin Analogs

Chemotherapy

Targeted Therapy

Preventive Asthma Drug Segment by Application

Oncology Centres

Clinics

Hospital

Preventive Asthma Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preventive Asthma Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preventive Asthma Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preventive Asthma Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Preventive Asthma Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Preventive Asthma Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Preventive Asthma Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Preventive Asthma Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Somatostatin Analogs Major Manufacturers Table 3. Chemotherapy Major Manufacturers Table 4. Targeted Therapy Major Manufacturers Table 5. Global Preventive Asthma Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Oncology Centres Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Hospital Major Manufacturers Table 9. Preventive Asthma Drug Industry Trends Table 10. Preventive Asthma Drug Industry Drivers Table 11. Preventive Asthma Drug Industry Opportunities and Challenges Table 12. Preventive Asthma Drug Industry Restraints Table 13. Global Preventive Asthma Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Preventive Asthma Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Preventive Asthma Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Preventive Asthma Drug Revenue Market Share by Region (2021-2026) Table 17. Global Preventive Asthma Drug Revenue Market Share by Region (2027-2032) Table 18. Global Preventive Asthma Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Preventive Asthma Drug Sales by Region (2021-2026) & (K Units) Table 20. Global Preventive Asthma Drug Sales by Region (2027-2032) & (K Units) Table 21. Global Preventive Asthma Drug Sales Market Share by Region (2021-2026) Table 22. Global Preventive Asthma Drug Sales Market Share by Region (2027-2032) Table 23. Global Preventive Asthma Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Preventive Asthma Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Preventive Asthma Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Preventive Asthma Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Preventive Asthma Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Preventive Asthma Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Preventive Asthma Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Preventive Asthma Drug Manufacturers, Product Type & Application Table 31. Global Preventive Asthma Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Preventive Asthma Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Preventive Asthma Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Preventive Asthma Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Preventive Asthma Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Preventive Asthma Drug Revenue Market Share by Type (2021-2026) Table 38. Global Preventive Asthma Drug Revenue Market Share by Type (2027-2032) Table 39. Global Preventive Asthma Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 41. Global Preventive Asthma Drug Sales by Type (2027-2032) & (K Units) Table 42. Global Preventive Asthma Drug Sales Market Share by Type (2021-2026) Table 43. Global Preventive Asthma Drug Sales Market Share by Type (2027-2032) Table 44. Global Preventive Asthma Drug Price by Type (2021-2026) & (US$/Unit) Table 45. Global Preventive Asthma Drug Price by Type (2027-2032) & (US$/Unit) Table 46. Global Preventive Asthma Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Preventive Asthma Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Preventive Asthma Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Preventive Asthma Drug Revenue Market Share by Application (2021-2026) Table 50. Global Preventive Asthma Drug Revenue Market Share by Application (2027-2032) Table 51. Global Preventive Asthma Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Preventive Asthma Drug Sales by Application (2027-2032) & (K Units) Table 54. Global Preventive Asthma Drug Sales Market Share by Application (2021-2026) Table 55. Global Preventive Asthma Drug Sales Market Share by Application (2027-2032) Table 56. Global Preventive Asthma Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Preventive Asthma Drug Price by Application (2027-2032) & (US$/Unit) Table 58. Callisto Pharmaceuticals Company Information Table 59. Callisto Pharmaceuticals Business Overview Table 60. Callisto Pharmaceuticals Preventive Asthma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Callisto Pharmaceuticals Preventive Asthma Drug Product Portfolio Table 62. Callisto Pharmaceuticals Recent Development Table 63. Molecular Insight Pharmaceuticals Company Information Table 64. Molecular Insight Pharmaceuticals Business Overview Table 65. Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Molecular Insight Pharmaceuticals Preventive Asthma Drug Product Portfolio Table 67. Molecular Insight Pharmaceuticals Recent Development Table 68. Xiaflex Company Information Table 69. Xiaflex Business Overview Table 70. Xiaflex Preventive Asthma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Xiaflex Preventive Asthma Drug Product Portfolio Table 72. Xiaflex Recent Development Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Preventive Asthma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Roche Preventive Asthma Drug Product Portfolio Table 77. Roche Recent Development Table 78. Novartis AG Company Information Table 79. Novartis AG Business Overview Table 80. Novartis AG Preventive Asthma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Novartis AG Preventive Asthma Drug Product Portfolio Table 82. Novartis AG Recent Development Table 83. North America Preventive Asthma Drug Revenue by Type (2021-2026) & (US$ Million) Table 84. North America Preventive Asthma Drug Revenue by Type (2027-2032) & (US$ Million) Table 85. North America Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 86. North America Preventive Asthma Drug Sales by Type (2027-2032) & (K Units) Table 87. North America Preventive Asthma Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 88. North America Preventive Asthma Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 89. North America Preventive Asthma Drug Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Preventive Asthma Drug Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 92. North America Preventive Asthma Drug Sales by Application (2027-2032) & (K Units) Table 93. North America Preventive Asthma Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 94. North America Preventive Asthma Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 95. North America Preventive Asthma Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Preventive Asthma Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 97. North America Preventive Asthma Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 98. North America Preventive Asthma Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 99. North America Preventive Asthma Drug Sales by Country (2021-2026) & (K Units) Table 100. North America Preventive Asthma Drug Sales by Country (2027-2032) & (K Units) Table 101. North America Preventive Asthma Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 102. North America Preventive Asthma Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 103. United States Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 104. Canada Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 105. Europe Preventive Asthma Drug Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Preventive Asthma Drug Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 108. Europe Preventive Asthma Drug Sales by Type (2027-2032) & (K Units) Table 109. Europe Preventive Asthma Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 110. Europe Preventive Asthma Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 111. Europe Preventive Asthma Drug Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Preventive Asthma Drug Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 114. Europe Preventive Asthma Drug Sales by Application (2027-2032) & (K Units) Table 115. Europe Preventive Asthma Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 116. Europe Preventive Asthma Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 117. Europe Preventive Asthma Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Preventive Asthma Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Preventive Asthma Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Preventive Asthma Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 121. Europe Preventive Asthma Drug Sales by Country (2021-2026) & (K Units) Table 122. Europe Preventive Asthma Drug Sales by Country (2027-2032) & (K Units) Table 123. Europe Preventive Asthma Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 124. Europe Preventive Asthma Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 125. Germany Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 126. France Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 127. U.K. Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 128. Italy Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 129. Netherlands Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 130. China Preventive Asthma Drug Revenue by Type (2021-2026) & (US$ Million) Table 131. China Preventive Asthma Drug Revenue by Type (2027-2032) & (US$ Million) Table 132. China Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 133. China Preventive Asthma Drug Sales by Type (2027-2032) & (K Units) Table 134. China Preventive Asthma Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 135. China Preventive Asthma Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 136. China Preventive Asthma Drug Revenue by Application (2021-2026) & (US$ Million) Table 137. China Preventive Asthma Drug Revenue by Application (2027-2032) & (US$ Million) Table 138. China Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 139. China Preventive Asthma Drug Sales by Application (2027-2032) & (K Units) Table 140. China Preventive Asthma Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 141. China Preventive Asthma Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Asia Preventive Asthma Drug Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Preventive Asthma Drug Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 145. Asia Preventive Asthma Drug Sales by Type (2027-2032) & (K Units) Table 146. Asia Preventive Asthma Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 147. Asia Preventive Asthma Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 148. Asia Preventive Asthma Drug Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Preventive Asthma Drug Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 151. Asia Preventive Asthma Drug Sales by Application (2027-2032) & (K Units) Table 152. Asia Preventive Asthma Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 153. Asia Preventive Asthma Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 154. Asia Preventive Asthma Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Preventive Asthma Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Asia Preventive Asthma Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Asia Preventive Asthma Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 158. Asia Preventive Asthma Drug Sales by Country (2021-2026) & (K Units) Table 159. Asia Preventive Asthma Drug Sales by Country (2027-2032) & (K Units) Table 160. Asia Preventive Asthma Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 161. Asia Preventive Asthma Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 162. Japan Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 163. South Korea Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 164. India Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 165. Australia Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 166. China Taiwan Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 167. Southeast Asia Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 168. SAMEA Preventive Asthma Drug Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Preventive Asthma Drug Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Preventive Asthma Drug Sales by Type (2021-2026) & (K Units) Table 171. SAMEA Preventive Asthma Drug Sales by Type (2027-2032) & (K Units) Table 172. SAMEA Preventive Asthma Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 173. SAMEA Preventive Asthma Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 174. SAMEA Preventive Asthma Drug Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Preventive Asthma Drug Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Preventive Asthma Drug Sales by Application (2021-2026) & (K Units) Table 177. SAMEA Preventive Asthma Drug Sales by Application (2027-2032) & (K Units) Table 178. SAMEA Preventive Asthma Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 179. SAMEA Preventive Asthma Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 180. SAMEA Preventive Asthma Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Preventive Asthma Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. SAMEA Preventive Asthma Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. SAMEA Preventive Asthma Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 184. SAMEA Preventive Asthma Drug Sales by Country (2021-2026) & (K Units) Table 185. SAMEA Preventive Asthma Drug Sales by Country (2027-2032) & (K Units) Table 186. SAMEA Preventive Asthma Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 187. SAMEA Preventive Asthma Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Brazil Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 189. Argentina Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 190. Chile Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 191. Colombia Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 192. Peru Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 193. Saudi Arabia Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 194. Israel Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 195. UAE Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 196. Turkey Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 197. Iran Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 198. Egypt Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Preventive Asthma Drug Distributors List Table 202. Preventive Asthma Drug Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Preventive Asthma Drug Image Figure 2. Global Preventive Asthma Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preventive Asthma Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Somatostatin Analogs Image Figure 5. Chemotherapy Image Figure 6. Targeted Therapy Image Figure 7. Global Preventive Asthma Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Preventive Asthma Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Oncology Centres Image Figure 10. Clinics Image Figure 11. Hospital Image Figure 12. Global Preventive Asthma Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Preventive Asthma Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Preventive Asthma Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Preventive Asthma Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Preventive Asthma Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Preventive Asthma Drug Sales (2021-2032) & (K Units) Figure 18. Global Preventive Asthma Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Preventive Asthma Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Preventive Asthma Drug Sales YoY (2021-2032) & (K Units) Figure 21. Europe Preventive Asthma Drug Sales YoY (2021-2032) & (K Units) Figure 22. China Preventive Asthma Drug Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Preventive Asthma Drug Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Preventive Asthma Drug Sales YoY (2021-2032) & (K Units) Figure 25. Global Preventive Asthma Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Preventive Asthma Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Preventive Asthma Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Preventive Asthma Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Preventive Asthma Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Preventive Asthma Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Preventive Asthma Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Preventive Asthma Drug Sales Market Share by Type (2021-2032) Figure 34. Global Preventive Asthma Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Preventive Asthma Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Preventive Asthma Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Preventive Asthma Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Preventive Asthma Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Preventive Asthma Drug Sales Market Share by Application (2021-2032) Figure 40. North America Preventive Asthma Drug Revenue Share by Type (2021-2032) Figure 41. North America Preventive Asthma Drug Sales Share by Type (2021-2032) Figure 42. North America Preventive Asthma Drug Revenue Share by Application (2021-2032) Figure 43. North America Preventive Asthma Drug Sales Share by Application (2021-2032) Figure 44. North America Preventive Asthma Drug Revenue Share by Country (2021-2032) Figure 45. North America Preventive Asthma Drug Sales Share by Country (2021-2032) Figure 46. Europe Preventive Asthma Drug Revenue Share by Type (2021-2032) Figure 47. Europe Preventive Asthma Drug Sales Share by Type (2021-2032) Figure 48. Europe Preventive Asthma Drug Revenue Share by Application (2021-2032) Figure 49. Europe Preventive Asthma Drug Sales Share by Application (2021-2032) Figure 50. Europe Preventive Asthma Drug Revenue Share by Country (2021-2032) Figure 51. Europe Preventive Asthma Drug Sales Share by Country (2021-2032) Figure 52. China Preventive Asthma Drug Revenue Share by Type (2021-2032) Figure 53. China Preventive Asthma Drug Sales Share by Type (2021-2032) Figure 54. China Preventive Asthma Drug Revenue Share by Application (2021-2032) Figure 55. China Preventive Asthma Drug Sales Share by Application (2021-2032) Figure 56. Asia Preventive Asthma Drug Revenue Share by Type (2021-2032) Figure 57. Asia Preventive Asthma Drug Sales Share by Type (2021-2032) Figure 58. Asia Preventive Asthma Drug Revenue Share by Application (2021-2032) Figure 59. Asia Preventive Asthma Drug Sales Share by Application (2021-2032) Figure 60. Asia Preventive Asthma Drug Revenue Share by Country (2021-2032) Figure 61. Asia Preventive Asthma Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Preventive Asthma Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Preventive Asthma Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Preventive Asthma Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Preventive Asthma Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Preventive Asthma Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Preventive Asthma Drug Sales Share by Country (2021-2032) Figure 68. Preventive Asthma Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Preventive Asthma Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Somatostatin Analogs
  • Chemotherapy
  • Targeted Therapy
Applications
  • Oncology Centres
  • Clinics
  • Hospital
Companies covered
  • Callisto Pharmaceuticals
  • Molecular Insight Pharmaceuticals
  • Xiaflex
  • Roche
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Preventive Asthma Drug Market by Type
  3. 1.2.1 Global Preventive Asthma Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Somatostatin Analogs
  5. 1.2.3 Chemotherapy
  6. 1.2.4 Targeted Therapy
  7. 1.3 Preventive Asthma Drug Market by Application
  8. 1.3.1 Global Preventive Asthma Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Oncology Centres
  10. 1.3.3 Clinics
  11. 1.3.4 Hospital
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Preventive Asthma Drug Market Dynamics
  1. 2.1 Preventive Asthma Drug Industry Trends
  2. 2.2 Preventive Asthma Drug Industry Drivers
  3. 2.3 Preventive Asthma Drug Industry Opportunities and Challenges
  4. 2.4 Preventive Asthma Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Preventive Asthma Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Preventive Asthma Drug Revenue by Region
  3. 3.2.1 Global Preventive Asthma Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Preventive Asthma Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Preventive Asthma Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Preventive Asthma Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Preventive Asthma Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Preventive Asthma Drug Sales by Region
  9. 3.4.1 Global Preventive Asthma Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Preventive Asthma Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Preventive Asthma Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Preventive Asthma Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Preventive Asthma Drug Revenue by Manufacturers
  2. 4.1.1 Global Preventive Asthma Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Preventive Asthma Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Preventive Asthma Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Preventive Asthma Drug Sales by Manufacturers
  6. 4.2.1 Global Preventive Asthma Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Preventive Asthma Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Preventive Asthma Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Preventive Asthma Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Preventive Asthma Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Preventive Asthma Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Preventive Asthma Drug Manufacturers, Product Type & Application
  13. 4.7 Global Preventive Asthma Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Preventive Asthma Drug Market CR5 and HHI
  16. 4.8.2 2025 Preventive Asthma Drug Tier 1, Tier 2, and Tier 3
5 Preventive Asthma Drug Market by Type
  1. 5.1 Global Preventive Asthma Drug Revenue by Type
  2. 5.1.1 Global Preventive Asthma Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Preventive Asthma Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Preventive Asthma Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Preventive Asthma Drug Sales by Type
  6. 5.2.1 Global Preventive Asthma Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Preventive Asthma Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Preventive Asthma Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Preventive Asthma Drug Price by Type
6 Preventive Asthma Drug Market by Application
  1. 6.1 Global Preventive Asthma Drug Revenue by Application
  2. 6.1.1 Global Preventive Asthma Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Preventive Asthma Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Preventive Asthma Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Preventive Asthma Drug Sales by Application
  6. 6.2.1 Global Preventive Asthma Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Preventive Asthma Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Preventive Asthma Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Preventive Asthma Drug Price by Application
7 Company Profiles
  1. 7.1 Callisto Pharmaceuticals
  2. 7.1.1 Callisto Pharmaceuticals Company Information
  3. 7.1.2 Callisto Pharmaceuticals Business Overview
  4. 7.1.3 Callisto Pharmaceuticals Preventive Asthma Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Callisto Pharmaceuticals Preventive Asthma Drug Product Portfolio
  6. 7.1.5 Callisto Pharmaceuticals Recent Developments
  7. 7.2 Molecular Insight Pharmaceuticals
  8. 7.2.1 Molecular Insight Pharmaceuticals Company Information
  9. 7.2.2 Molecular Insight Pharmaceuticals Business Overview
  10. 7.2.3 Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Molecular Insight Pharmaceuticals Preventive Asthma Drug Product Portfolio
  12. 7.2.5 Molecular Insight Pharmaceuticals Recent Developments
  13. 7.3 Xiaflex
  14. 7.3.1 Xiaflex Company Information
  15. 7.3.2 Xiaflex Business Overview
  16. 7.3.3 Xiaflex Preventive Asthma Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Xiaflex Preventive Asthma Drug Product Portfolio
  18. 7.3.5 Xiaflex Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Preventive Asthma Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roche Preventive Asthma Drug Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Novartis AG
  26. 7.5.1 Novartis AG Company Information
  27. 7.5.2 Novartis AG Business Overview
  28. 7.5.3 Novartis AG Preventive Asthma Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis AG Preventive Asthma Drug Product Portfolio
  30. 7.5.5 Novartis AG Recent Developments
8 North America
  1. 8.1 North America Preventive Asthma Drug Market Size by Type
  2. 8.1.1 North America Preventive Asthma Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Preventive Asthma Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Preventive Asthma Drug Price by Type (2021-2032)
  5. 8.2 North America Preventive Asthma Drug Market Size by Application
  6. 8.2.1 North America Preventive Asthma Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Preventive Asthma Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Preventive Asthma Drug Price by Application (2021-2032)
  9. 8.3 North America Preventive Asthma Drug Market Size by Country
  10. 8.3.1 North America Preventive Asthma Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Preventive Asthma Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Preventive Asthma Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Preventive Asthma Drug Market Size by Type
  2. 9.1.1 Europe Preventive Asthma Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Preventive Asthma Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Preventive Asthma Drug Price by Type (2021-2032)
  5. 9.2 Europe Preventive Asthma Drug Market Size by Application
  6. 9.2.1 Europe Preventive Asthma Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Preventive Asthma Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Preventive Asthma Drug Price by Application (2021-2032)
  9. 9.3 Europe Preventive Asthma Drug Market Size by Country
  10. 9.3.1 Europe Preventive Asthma Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Preventive Asthma Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Preventive Asthma Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Preventive Asthma Drug Market Size by Type
  2. 10.1.1 China Preventive Asthma Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Preventive Asthma Drug Sales by Type (2021-2032)
  4. 10.1.3 China Preventive Asthma Drug Price by Type (2021-2032)
  5. 10.2 China Preventive Asthma Drug Market Size by Application
  6. 10.2.1 China Preventive Asthma Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Preventive Asthma Drug Sales by Application (2021-2032)
  8. 10.2.3 China Preventive Asthma Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Preventive Asthma Drug Market Size by Type
  2. 11.1.1 Asia Preventive Asthma Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Preventive Asthma Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Preventive Asthma Drug Price by Type (2021-2032)
  5. 11.2 Asia Preventive Asthma Drug Market Size by Application
  6. 11.2.1 Asia Preventive Asthma Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Preventive Asthma Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Preventive Asthma Drug Price by Application (2021-2032)
  9. 11.3 Asia Preventive Asthma Drug Market Size by Country
  10. 11.3.1 Asia Preventive Asthma Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Preventive Asthma Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Preventive Asthma Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Preventive Asthma Drug Market Size by Type
  2. 12.1.1 SAMEA Preventive Asthma Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Preventive Asthma Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Preventive Asthma Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Preventive Asthma Drug Market Size by Application
  6. 12.2.1 SAMEA Preventive Asthma Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Preventive Asthma Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Preventive Asthma Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Preventive Asthma Drug Market Size by Country
  10. 12.3.1 SAMEA Preventive Asthma Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Preventive Asthma Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Preventive Asthma Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Preventive Asthma Drug Value Chain Analysis
  2. 13.1.1 Preventive Asthma Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Preventive Asthma Drug Production Mode & Process
  6. 13.2 Preventive Asthma Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Preventive Asthma Drug Distributors
  9. 13.2.3 Preventive Asthma Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst